• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 14
  • 2
  • 2
  • 1
  • 1

PRICE

18
18
18
20

PUBLISHED

0
0
0
20

PRODUCT TYPE

18
2

Search "CSL Limited - Product Pipeline Review - Q4 2010" returned 20 results.

PRODUCT TITLE
CSL Limited - Product Pipeline Review - Q4 2010 CSL Limited - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

CSL Limited - Product Pipeline Review - Q4 2010

CSL Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “CSL Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research and...

December 2010
FROM
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Thumbnail Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest...

July 2013
FROM
Patrys Limited - Product Pipeline Review - Q4 2010 Patrys Limited - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Patrys Limited - Product Pipeline Review - Q4 2010

Patrys Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Patrys Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research...

December 2010
FROM
Primary Immune Deficiency (PID) - Pipeline Review, H2 2012 Primary Immune Deficiency (PID) - Pipeline Review, H2 2012 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Review, H2 2012

Primary Immune Deficiency (PID) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Primary Immune Deficiency (PID) - Pipeline Review, H2 2012', provides an overview of the Primary Immune...

July 2012
FROM

Von Willebrand Disease - Pipeline Review, Q4 2010

Von Willebrand Disease - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Von Willebrand Disease Pipeline Review, Q4 2010”, provides an overview of the Von Willebrand Disease therapeutic...

December 2010
FROM

Hemophilia - Pipeline Review, Q4 2010

Hemophilia - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Hemophilia Pipeline Review, Q4 2010”, provides an overview of the Hemophilia therapeutic pipeline. This report provides information...

December 2010
FROM

Hemophilia B - Pipeline Review, Q4 2010

Hemophilia B - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Hemophilia B Pipeline Review, Q4 2010”, provides an overview of the Hemophilia B therapeutic pipeline. This report provides...

December 2010
FROM

Influenza - Pipeline Review, Q4 2010

Influenza - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Influenza Pipeline Review, Q4 2010”, provides an overview of the Influenza therapeutic pipeline. This report provides information...

December 2010
FROM

Hemophilia A - Pipeline Review, Q4 2010

Hemophilia A - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Hemophilia A Pipeline Review, Q4 2010”, provides an overview of the Hemophilia A therapeutic pipeline. This report provides...

December 2010
FROM

Hemophilia - Pipeline Review, Q1 2011

Hemophilia - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Hemophilia - Pipeline Review, Q1 2011', provides an overview of the Hemophilia therapeutic pipeline. This report provides information...

March 2011
FROM

Acute Coronary Syndromes - Pipeline Review, Q4 2010

Acute Coronary Syndromes - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Acute Coronary Syndrome Pipeline Review, Q4 2010”, provides an overview of the Acute Coronary Syndrome therapeutic...

December 2010
FROM

Hemophilia B - Pipeline Review, Q1 2011

Hemophilia B - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Hemophilia B - Pipeline Review, Q1 2011', provides an overview of the Hemophilia B therapeutic pipeline. This report provides...

February 2011
FROM

Acute Coronary Syndromes - Pipeline Review, Q1 2011

Acute Coronary Syndromes - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Acute Coronary Syndromes - Pipeline Review, Q1 2011', provides an overview of the Acute Coronary Syndrome therapeutic...

February 2011
FROM

Melanoma - Pipeline Review, Q4 2010

Melanoma - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Melanoma Pipeline Review, Q4 2010”, provides an overview of the Melanoma therapeutic pipeline. This report provides information...

December 2010
FROM
Rheumatoid arthritis - Pipeline Review, Q4 2010 Rheumatoid arthritis - Pipeline Review, Q4 2010 - Product Thumbnail Image

Rheumatoid arthritis - Pipeline Review, Q4 2010

Rheumatoid arthritis - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Rheumatoid Arthritis Pipeline Review, Q4 2010”, provides an overview of the Rheumatoid Arthritis therapeutic pipeline....

December 2010
FROM

Rheumatoid Arthritis - Pipeline Review, Q1 2011

Rheumatoid Arthritis - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Rheumatoid Arthritis - Pipeline Review, Q1 2011', provides an overview of the Rheumatoid Arthritis therapeutic pipeline....

February 2011
FROM

Melanoma - Pipeline Review, Q1 2011

Melanoma - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, Q1 2011', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

February 2011
FROM
Prescription Drugs - Global Strategic Business Report Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

July 2009
FROM

Acute Myelocytic Leukemia (AML) - Pipeline Review, Q1 2011

Acute Myelocytic Leukemia (AML) - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML) - Pipeline Review, Q1 2011', provides an overview of the Acute Myelocytic...

February 2011
FROM

Acute Myelocytic Leukemia (AML) - Pipeline Review, Q4 2010

Acute Myelocytic Leukemia (AML) - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Acute Myelocytic Leukemia Pipeline Review, Q4 2010”, provides an overview of the Acute Myelocytic Leukemia...

December 2010
FROM
Loading Indicator